Progyny, Inc.

NASDAQ:PGNY

20.75 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 286.625304.087278.078269.94280.891279.373258.394214.321205.371195.004172.217127.553122.284128.651122.133100.30198.92864.60581.02465.12261.19656.16847.19729.18727.79826.15722.258
Cost of Revenue 227.381235.806215.672213.046218.267218.732199.754169.827159.376151.117139.268102.43893.79299.0393.22679.63578.09252.6564.42253.35348.87644.71637.23323.77222.75121.11918.324
Gross Profit 59.24468.28162.40656.89462.62460.64158.6444.49445.99543.88732.94925.11528.49229.62128.90720.66620.83611.95516.60211.76912.3211.4529.9645.4155.0475.0383.934
Gross Profit Ratio 0.2070.2250.2240.2110.2230.2170.2270.2080.2240.2250.1910.1970.2330.230.2370.2060.2110.1850.2050.1810.2010.2040.2110.1860.1820.1930.177
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 30.32931.17328.42928.18329.52430.07329.34728.20823.57423.55322.99217.60714.98613.93713.08614.72912.1210.1679.4767.376.0685.9814.5083.9753.9863.6243.794
Selling & Marketing Expenses 16.45716.42115.45414.91114.91115.38414.28212.9811.16611.49610.0157.6964.4414.0284.0144.7763.3553.6083.2673.2553.1833.1172.3462.1431.6481.7311.763
SG&A 46.78647.59443.88343.09444.43545.45743.62941.18834.7435.04933.00725.30319.42717.96517.119.50515.47513.77512.74310.6259.2519.0986.8546.1185.6345.3555.779
Other Expenses 003.361.721.7081.2770.4980.2750.0820.025-0.096-0.293-0.0920.0120.0070.0320.0110.0030.16400000000
Operating Expenses 46.78647.59443.88343.09444.43545.45743.62941.18834.7435.04933.00725.30319.42717.96517.119.50515.47513.77512.74310.6259.2519.0986.8546.1185.6345.8145.963
Operating Income 12.45820.68718.52313.818.18915.18415.0113.30611.2558.838-0.058-0.1889.06511.65611.8071.1615.361-1.823.8591.1443.0692.3543.11-0.703-0.587-0.317-1.845
Operating Income Ratio 0.0430.0680.0670.0510.0650.0540.0580.0150.0550.045-0-0.0010.0740.0910.0970.0120.054-0.0280.0480.0180.050.0420.066-0.024-0.021-0.012-0.083
Total Other Income Expenses Net 5.5044.383.9922.4622.7421.9831.320.8350.2840.065-0.084-0.210.0520.264-0.0110.015-0.0060.0080.314-5.621-11.254-0.77-0.589-1.421-0.945-0.803-0.272
Income Before Tax 17.96225.06722.51516.26220.93117.16716.3314.14111.5398.903-0.142-0.3989.11711.9211.7961.1765.355-1.8124.173-4.477-8.1851.5842.521-2.124-1.532-1.12-2.117
Income Before Tax Ratio 0.0630.0820.0810.060.0750.0610.0630.0190.0560.046-0.001-0.0030.0750.0930.0970.0120.054-0.0280.052-0.069-0.1340.0280.053-0.073-0.055-0.043-0.095
Income Tax Expense 7.5418.5825.6172.7925.0332.176-1.3470.733-1.6720.135-5.113-15.478-7.679-6.807-3.37-37.8960.017-0.0050.116-0.0770.0250.0640.589-0.547-0.3950.2890.546
Net Income 10.42116.48516.89813.4715.89814.99117.6783.40813.2118.7684.97115.0816.79618.72715.16639.0725.355-1.8124.057-4.4-8.211.522.521-1.525-1.136-0.831-1.571
Net Income Ratio 0.0360.0540.0610.050.0570.0540.0680.0160.0640.0450.0290.1180.1370.1460.1240.390.054-0.0280.05-0.068-0.1340.0270.053-0.052-0.041-0.032-0.071
EPS 0.120.180.180.140.170.160.190.0370.140.090.050.170.190.210.170.450.06-0.0210.05-0.069-0.10.0220-0.022-0.016-0.15-0.28
EPS Diluted 0.110.170.170.130.160.150.180.0340.130.0880.050.150.170.190.150.390.05-0.0210.04-0.069-0.10.0190-0.022-0.014-0.15-0.28
EBITDA 12.45821.44119.23914.43418.76815.71115.5523.75211.669.2240.3060.1289.33211.95212.2291.6255.823-0.6124.3791.6833.6043.5453.62-0.215-0.1130.156-1.397
EBITDA Ratio 0.0430.0710.0690.0510.0670.0560.060.0180.0550.0470.0020.0010.0740.0930.10.0160.059-0.0210.0540.1140.2340.0630.0880.040.0290.006-0.063